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Abstract: Using a common 1-(1-phenylethenyl)-1,2,3,4-tetrahydroisoquinoline precursor 
to the required ylide or N-oxide intermediate, the Stevens [2,3] and analogous 
Meisenheimer [2,3] sigmatropic rearrangements have been applied to afford concise 
syntheses of phenyl -substituted representatives of each of the reduced 1H-3-benzazonine 
and 4,3-benzoxazonine systems, respectively. Single crystal X-ray structure determinations 
were employed to define the conformational characteristics for each ring type. 
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Annulated medium-ring heterocycles have attracted significant research attention owing to the vast 
array of systems possible with potential for different chemical and biological properties [1–4].  
For example, some 3-benzazonines with a nine-membered ring show 5-HT2A antagonist activity [5], 
while the eight-membered ring-containing benzoxazocines display a range of biological properties 
including analgesic [6] and NK1 (neurokinin receptor) inhibitory activity [7]. Synthetic approaches to 
these systems often involve rearrangement strategies incorporating a ring expansion [8–11], although 
ring formation [12–14] and ring cleavage approaches [5,15,16] can also be used. The Meisenheimer [1,2] 
and [2,3] sigmatropic rearrangements of amine N-oxides [17–19] and the analogous Stevens [2,3] 
sigmatropic rearrangements of ylides [20,21] afford good opportunities for medium ring synthesis.  
To further explore these synthetic prospects and to assess substituent effects (e.g., a phenyl group vs. a 
methyl group or hydrogen [17]) on configurational and conformational issues in the products, we have 
investigated the synthetic utility of the [2,3] versions of these rearrangements from the same  
starting amine precursor, the 1-(1-phenylethenyl) substituted tetrahydroisoquinoline derivative 3.  
These rearrangements involve three-atom ring expansions with incorporation of an O-C-C 
(Meisenheimer) or C-C-C (Stevens) unit into the six-membered N-containing ring. Soldatenkov et al. 
have also reported that a tetrahydroisoquinoline N-ylide can undergo a somewhat related [1,4] 
sigmatropic rearrangement on reaction with dimethyl acetylenedicarboxylate affording a 3-benzazonine 
derivative in good yield [22]. The results of our work and the single crystal X-ray structural analyses 
of the benzo-fused nine-membered ring heterocycles produced are discussed in this paper. 
2. Results and Discussion 
2.1. Synthesis 
The synthesis of the fused medium ring compounds 1 and 2 proceeded from the common starting 
tetrahydroisoquinoline derivative 3 (Scheme 1), readily accessible in turn by nucleophilic addition of 
the Grignard reagent 1-phenylethenylmagnesium bromide to the known salt 6,7-dimethoxy-2-methyl-
3,4-dihydroisoquinolinium iodide [23]. 
 
Scheme 1. Synthesis of the benzazonine 1 and benzoxazonine 2. 
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Reaction of the tetrahydroisoquinoline 3 with ethyl bromoacetate gave a diastereomeric mixture  
of the quaternary salts which, on treatment with DBU in acetonitrile at 25 °C, gave mainly the  
nine-membered 3-benzazonine 1 as a mixture of the E and Z diastereomers from the ylide 4 and a 
Stevens [2,3] rearrangement. A very minor amount of the Stevens [1,2] rearrangement product 6  
(Figure 1, 8% yield based on 1H-NMR analysis) was also formed as an inseparable mixture (HPLC) 
with a trace of another compound tentatively assigned as the isomeric ring-opened product 8  
(Figure 1); a little more of both 6 and 8 were formed on repeating the reaction in acetonitrile heated at 
reflux but they could not be separated. The structure of the benzazepine 6 followed from the 1H-NMR 
spectral data on the mixture, particularly the characteristic coupled doublet signals ascribed to H1 
(3.66 ppm) and H2 (4.50 ppm), while for the ring-opened product 8, diagnostic signals consistent with 
an isolated mono-substituted vinyl group, a separate olefinic proton, and two isolated N-methylene 
protons (singlets at 3.61 and 3.15 ppm in the 1H-NMR and at 58.3 and 55.2 ppm in the 13C-NMR) 
were apparent. Potentially this latter product could arise via a thermal 1,3-rearrangement [24,25] of the 
tetrahydroisoquinoline 3 to an eight-membered 5-phenyl-3-benzazocine intermediate and subsequent 
N-quaternization followed by a DBU-mediated Hofmann elimination to give 8 with the E geometry 
about the stilbenic double bond. 
 
Figure 1. Proposed structures for the benzazepine 6 and ring-opened compound 8. 
The diastereomers of the benzazonine 1 were separated by preparative HPLC and their structures 
were elucidated initially on the basis of NMR, mass spectrometric and elemental analytical data. 
Consistent with the nine-membered ring structure was the presence of a singlet signal downfield at 
6.91 ppm in the 1H-NMR (C6D6 room temperature; 13C-NMR, C7 at 130.5 ppm) or 6.74 ppm (C6D6, 
75 °C; 13C-NMR, C7 at 131.5 ppm) ascribed to the vinylic proton H7 in the E and Z diastereomers, 
respectively. The E vs. Z stereochemistry was assigned on the basis of a nOe interaction between H7 
and the ortho-6-phenyl protons in the E-1 diastereomer but not the Z-1 diastereomer. The benzazonine 
Z-1 exhibited conformational flexibility on the basis of the 1H-NMR spectral analysis at 25 °C in either 
C6D6 or CDCl3. Broad peaks lacking definition were observed. At 75 °C in C6D6 a single set of signals 
was obtained for Z-1 which supported the proposed structure. At this temperature only the signals 
ascribed to H5 and the ethyl ester protons displayed poor peak shape. At −50 °C in CDCl3, two 
conformations in a ratio of about 1.94:1 appeared, with substantially different diagnostic singlet signals 
at 2.36 and 2.69 ppm (N-Me group) and multiplet signals at 1.41–1.35 and 0.87–0.81 ppm (ester 
methyl group) for the major and minor conformations, respectively. 
Conversion of the tetrahydroisoquinoline 3 to the N-oxide derivative was achieved by oxidation 
with m-CPBA in dichloromethane at room temperature to afford the trans-N-oxide 5 (53%), together 
with a substantial yield of a mixture (up to 25%; 44:56 ratio) of the isomeric rearranged products 2 and 7. 
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Only the Z-diastereomer of the nine-membered ring benzoxazonine 2 was observed. Similar results 
were obtained on oxidation with cooling of the solution during the reaction and on work up.  
The Meisenheimer [2,3] rearrangement product 2 and the Meisenheimer [1,2] rearrangement product 7 
were isolated by preparative HPLC. In the 1H-NMR of the benzoxazonine 2 at 25 °C in CDCl3, the H7 
olefinic proton appeared as a downfield singlet at 7.00 ppm, while the H1 and H2 methylene proton 
signals were broad and integrating as only 2–3 protons. At low temperature (−30 °C), two conformers 
of the benzoxazonine 2 (ca. 3.5:1 ratio) were apparent in the 1H and 13C-NMR spectra, which were 
probably related by the inversion or “flipping” of the N3-O4-C5 segment of the medium ring. With the 
seven-membered ring product 7, downfield singlet signals at 5.98 and 5.53 ppm in the 1H-NMR were 
consistent with the presence of the methylidene group, while H1 was ascribed to the singlet signal 
further upfield at 5.15 ppm. 
Furthermore, a solution of the benzoxazonine 2 in acetonitrile heated at reflux led to slow 
isomerisation via a [1,3] shift to yield the benzoxazepine 7; an equilibrium between 2 and 7 (ca. 24:76 
ratio, 2:7) was obtained on heating either 2 or 7 at a higher temperature in refluxing xylene for 1 h. 
In both the Stevens and Meisenheimer [2,3] rearrangements, the cis isomer of the respective 
intermediate N-ylide 4 or N-oxide 5 is involved, as a favourable concerted transition state  
geometry [19,21] can be accessed to give the nine-membered ring products. On the other hand, with 
the corresponding trans-isomeric ylide or N-oxide, this is not the case, and the diradical mediated [1,2] 
rearrangements to give seven-membered ring products can then proceed. Interestingly, with a  
1-ethenyl or 1-isopropenyl substituent in the tetrahydroisoquinoline precursor of the corresponding 
ylide, only the Stevens [2,3] rearrangement products were observed, while the analogous N-oxides 
gave only the Meisenheimer [1,2] rearrangement product (from the 1-ethenyl precursor) or a mixture 
of the [1,2] and [2,3] rearrangement products (from the 1-isopropenyl precursor) on heating at reflux in 
acetonitrile for 50 min [17]. 
2.2. X-ray Structural Studies 
To support the structural elucidations, single crystals of the 3-benzazonine E-1 and of the  
4,3-benzoxazonine 2 were obtained for X-ray crystallographic analysis. Suitable crystals for an X-ray 
study of Z-1 could not be obtained. 
The results of the single crystal X-ray studies on E-1 and 2 were consistent with the above 
formulations in terms of stoichiometry and connectivity (Figure 2a,b, Tables 1–3), establishing  
solid-state conformations, and with bond distances and angles generally conforming to expected 
norms. Counterpart values and figures for two closely related systems (CCDC: AYEKOF [26], 
SELXUC [27]; see Figure 4 for structures) are also included for comparison. 
The crystal packings are of some interest, with that of E-1 comprising sheets normal to c  
(Figure 3a), similar to that normal to b observed with AYEKOF [26] (Figure 3c), while 2 is a simple 
translational stacking up b (Figure 3b). The fused aromatic rings with their ortho-methoxy substituents 
are unremarkable, the methyl groups lying quasi-coplanar with the aromatic ring with the usual 
exocyclic angle asymmetries at the pendant bonds, and their phenyl pendants quasi-normal to the 
supporting phenyl ring plane (Figure 4a,b). 
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The principal interest in the two structures E-1 and 2 lies in the novelty of their macrocycle 
components. There are diverse analogues of E-1 structurally characterized in the literature,  
perhaps the most relevant benzo-fused systems with similarly located nitrogen atoms being those of a  
1α,3α,7β-2,3,4,5,6,7-tetrahydro-3,7-dimethyl-1-phenyl-1H-3-benzazonine N-oxide-saccharin complex [27] 
[(CCDC: SELXUC)], albeit with a more heavily substituted nitrogen atom and lacking the double 
bond, and of dimethyl 4-cyano-3-methyl-2,3,6,7-tetrahydro-1H-3-benzazonine-5,6-dicarboxylate [26] 
[(CCDC: AYEKOF)], also with a quaternary nitrogen atom with the C=C bond adjacent to it (rather 
than distant) in the ring. To the best of our knowledge, there are no other X-ray crystallographic 
studies on derivatives with the 4,3-benzoxazonine system as in 2. 
(a) (b) 
Figure 2. Molecular projections of E-1 (a); 2 (b), normal to the “planes” of their 
“macrocycle” rings; the R enantiomer, arbitrarily adopted as the asymmetric unit in a 
centrosymmetric space group, is shown in (a). 
Table 1. “Macrocycle” torsion angles (degrees) (E-1, 2; counterpart values for (CCDC) 
AYEKOF [26], SELXUC [27] are also given.). Atoms are denoted by number only,  
N italicized; note that atom 4 in 2 is oxygen. 
Compound E-1 2 AYEKOF [26] SELXUC [27] 
11a-1-2-3 105.2 (2) 52.56 (12) −68.4 (2) −43.3 (3) 
1-2-3-4 −105.0 (2) 63.90 (11) −64.1 (2) 75.3 (3) 
2-3-4-5 55.8 (2) −122.48 (8) 104.4 (2) 50.8 (2) 
3-4-5-6 59.0 (2) 113.25 (9) 2.8 (3) −109.4 (2) 
4-5-6-7 −118.1 (2) −90.31 (12) −96.1 (2) 54.2 (3) 
5-6-7-7a 0.9 (2) 4.0 (2) 110.4 (2) −72.1 (3) 
6-7-7a-11a 70.0 (2) 69.59 (14) −76.7 (2) 105.4 (3) 
7-7a-11a-1 2.1 (2) −3.32 (15) −2.4 (3) 4.3 (3) 
7a-11a-1-2 −91.6 (2) −109.39 (11) 104.4 (2) −60.4 (3) 
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Table 2. Selected geometries (E-1, 2; counterpart values for AYEKOF (100 K) [26], SELXUC (293 K) [27] are also given.) *. 
Atoms Parameter (Macrocycle) Atoms Parameter (Phenyl Ring) 
Distances (Å) 
C(1)-C(2) 1.544(2), 1.5259(15), 1.522(3), 1.539(3) C(7a)-C(8) 1.409(2), 1.4105(14), 1.401(3), 1.389(4) 
C(1)-C(11a) 1.512(2), 1.5129(14), 1.513(3), 1.521(2) C(7a)-C(11a) 1.389(2), 1.3918(13), 1.405(3), 1.406(4) 
C(2)-N(3) 1.475(2), 1.4588(14), 1.483(3), 1.504(3) C(8)-C(9) 1.370(2), 1.3834(13), 1.389(3), 1.357(4) 
N(3)-C,O(4) 1.450(2), 1.4544(10), 1.431(3), 1.518(4) C(9)-C(10) 1.396(2), 1.4101(13), 1.383(3), 1.370(5) 
N(3)-C(3) 1.459(2), 1.4590(14), 1.470(3), 1.491(3) C(10)-C(11) 1.380(2), 1.3836(13), 1.388(3), 1.381(4) 
C,O(4)-C(5) 1.533(2), 1.4453(12), 1.346(3), 1.517(4) C(11)-C(11a) 1.407(2), 1.4094(13), 1.397(3), 1.390(3) 
C(5)-C(6) 1.509(2), 1.5106(13), 1.505(3), 1.522(4) C(9)-O(9) 1.371(2), 1.3683(11), -, - 
C(6)-C(7) 1.340(2), 1.3431(13), 1.555(3), 1.534(4) C(10)-O(10) 1.370(2), 1.3651(11), -, - 
C(7)-C(7a) 1.483(2), 1.4876(13), 1.511(3), 1.515(3)   
C(6)-C(61) 1.488(2), 1.4892(13), 1.524(3), -    
Angles (degrees) 
C(11a)-C(1)-C(2) 115.71(13), 113.11(8), 113.9(2), 117.2(2) C(7)-C(7a)-C(8) 117.16(14), 118.12(8), 118.5(2), 118.6(3) 
C(1)-C(2)-N(3) 113.79(13), 111.51(8), 113.5(2), 116.3(2) C(7)-C(7a)-C(11a) 123.75(14), 122.46(9), 122.7(2), 123.4(2) 
C(2)-N(3)-C,O(4) 117.61(13), 106.90(7), 112.0(2), 115.8(2) C(8)-C(7a)-C(11a) 119.09(14), 119.29(8), 118.8(2), 117.9(2) 
C(2)-N(3)-C(3) 113.73(13), 111.35(9), 110.0(2), 111.6(2) C(7a)-C(8)-C(9) 121.82(16). 121.48(9), 121.4(2), 122.6(3) 
C,O(4)-N(3)-C(3) 112.03(12), 105.62(8), 112.3(2), 111.2(2) C(8)-C(9)-O(9) 125.26(16), 125.56(9), -, - 
N(3)-C,O(4)-C(5) 112.08(12), 108.87(7), 121.5(2), 113.7(2) C(10)-C(9)-O(9) 115.41(15), 115.25(8), -, - 
C,O(4)-C(5)-C(6) 113.93(13), 112.02(8), 120.9(2), 118.1(2) C(8)-C(9)-C(10) 119.32(15), 119.19(9), 119.7(2), 119.6(3) 
C(5)-C(6)-C(7) 121.28(14), 121.43(9), 113.3(2), 118.3(3) C(9)-C(10)-C(11) 119.51(15), 119.44(9), 119.5(2), 119.9(2) 
C(5)-C(6)-C(61) 118.25(13), 118.33(8), 111.3(2), - C(9)-C(10)-O(10) 114.75(15), 115.29(8), -, - 
C(61)-C(6)-C(7) 120.31(14), 120.24(9), 112.3(2), - C(11)-C(10)-O(10) 125.73(16), 125.27(9), -, - 
C(6)-C(7)-C(7a) 124.86(14), 126.88(9), 112.44(14), 110.8(2) C(10)-C(11)-C(11a) 121.66(16), 121.54(9), 121.6(2), 121.1(3) 
  C(11)-C(11a)-C(7a) 118.57(15), 119.00(9), 119.0(2), 118.9(2) 
  C(11)-C(11a)-C(1) 118.73(14), 118.00(8), 118.0(2), 117.6(2) 
  C(7a)-C(11a)-C(1) 122.70(14), 122.98(8), 123.0(2), 123.5(2) 
  C(9)-O(9)-C(91) 115.93(14), 116.82(8), -, - 
  C(10)-O(10)-C(101) 117.91(15), 116.86(8), -, - 
* For the oxygen atom pendant at N(3), N-O is 1.4275(14) Å, O-N-C(9,10,3) are 102.19(12), 107.16(13), 108.11(15)°. For the methyl group pendant at C(7), (H3)C-C(7) 
is 1.529(4) Å; C-C-C(6,7a) are 110.7(3), 111.5(2)°; for the phenyl pendant at C(1), C-C is 1.526(3) Å; C-C-C(2,11a) are 109.70(15), 112.34(15)°. 
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Table 3. Crystal refinement data, E-1, 2. 
Compound E-1 2 
Formula C24H29NO4 C20H23NO3 
Fw (Da) 395.5 325.4 
Crystal system Orthorhombic Monoclinic 
Space group Pbca (# 61) P21/n (#14 (variant)) 
a (Å) 12.321(1) 16.5518(6) 
b (Å) 13.400(1) 6.1433(2) 
c (Å) 25.698(3) 17.8034(6) 
β (°)  106.931(4) 
V (Å3) 4243(1) 1731.8(1) 
T (K) 150 100 
Dc (gcm
−3) 1.238 1.248 
Z (f.u.) 8 4 
μ (mm−1) 0.084 0.083 
Specimen (mm3) 0.36 × 0.15 × 0.10 0.43 × 0.16 × 0.15 
Tmin/max 0.77 0.97 
2θmax (deg.) 58 60 
Nt 50344 17112 
N 5582 (0.030) 5052 (0.022) 
No (I > 2σ(I)) 3101 4391 
R1 (I > 2σ(I)) 0.053 0.043 
wR2 (a(b)) 0.15 (0.088) 0.111 (0.053, 0.58) 




Figure 3. (a) Unit cell contents of E-1, projected down a, showing the layering normal to 
c; (b) Unit cell contents of 2, projected down b; (c) Unit cell contents of AYEKOF [26], 
projected down c, showing the layering normal to b (cf. (a)). 








Figure 4. The molecular cores of E-1 (a); 2 (b); AYEKOF [26] (c) and SELXUC [27] (d); 
projected through the parent aromatic ring as a “baseline” at the bottom of the 
“macrocycle” of each picture, and displaying the separate macrocycle conformations. 
Notes: In AYEKOF, the protonating hydrogen atom at the nitrogen atom, although shown in Figure 1 of 
reference [26], is not included in the CCDC cif file, and was restored as an estimate by us for the purpose of 
the present Figure; the macrocycle double bond is located on the other side of the ring nitrogen atom, 
between it and the parent phenyl ring in this species. 
The conformations of the strings from C(5) to C(1), inclusive of the aromatic bond, are similar in 
both E-1 and 2 (Figure 4a,b), but there are substantial differences between C(1)…C(5), with inversion 
at N(3) and a substantial difference in the angle sums about it: 343.3 in E-1, 323.6° in 2, reflecting the 
difference in the N(3)-X(4) substituent and associated distances [1.450(2) in E-1 (X = C), 1.4544(10) Å 
in 2 (X = O)]. It is not clear however, which of the two conformations seen in solution at low 
temperature for E-1 and 2 correlate with the ring conformation for each seen in the solid state. Further 
studies are required to elucidate this. In each of these two compounds, as well as AYEKOF and 
SELXUC, with quaternary nitrogen atoms and with the double bond differently located or absent 
(Figure 4c,d), all of the macrocycle string lies to one side of the supporting aromatic ring plane. 
However, the conformations are different in each compound; a consequence of the diversity of string 
components and associated substituents. With related N,O-containing, nine-membered, reduced  
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2,6-benzoxazonine derivatives [28], the conformations adopted in the crystalline state (MOSXIB and 
MOSXOH [28]) were shown to be the same as those in solution. 
High level calculations are required on the benzo-fused aza and oxaza ring systems in the present 
work in order to further probe the solution and solid state conformational landscape of these interesting 
heterocyclic systems. 
3. Experimental Section 
3.1. General 
Microanalyses were carried out by the Central Science Laboratory, University of Tasmania,  
Hobart. Melting points were determined on a Yanagimoto Seisakusho micromelting point apparatus, 
and are uncorrected. Infrared spectra were recorded on a Digilab FTS-20E Fourier transform 
spectrometer. The 1H and 13C-NMR spectra were recorded on a Bruker AM-300 spectrometer at 300 
and 75 MHz, respectively. Chemical shifts in ppm (δ) were measured relative to tetramethylsilane. 
Unless otherwise stated, the NMR spectra were measured in deuterated chloroform. Peaks are reported 
as singlet (s), broad singlet (bs), doublet (d), triplet (t), quartet (q) or multiplet (m). Where samples in 
the 13C-NMR exhibited several conformers, or isomers, the chemical shift for the major form is given 
first for each signal type; different forms are denoted with superscripts a,b or x,y in the lH-NMR 
spectra. The mass spectra were recorded on either a VG MM 7070F or a Kratos Concept ISQ mass 
spectrometer operating at 70 eV. Peak intensities in parentheses are expressed as a percentage of the 
base peak. Analytical thin layer chromatography (t.l.c.) and preparative thin layer chromatography 
(p.t.l.c.) were performed on either Merck silica gel 60 F254 or Camag DSF-5 aluminium oxide. All 
column chromatography was performed under medium-pressure (“flash chromatography”) on either 
Merck silica gel 60, 230–400 mesh, or on type H aluminium oxide, 100–200 mesh. Preparative HPLC 
utilised a Dynamax-604 C18 reverse-phase column with a Waters 600 multisolvent delivery system 
and Waters 486 tunable UV detector. Samples were eluted at 10 mL/min and monitored at 254 nm. 
Mixtures of the chromatography solvents were made up by volume. Organic solvent extracts were 
dried with anhydrous sodium sulfate. Where reaction mixture solutions or solvent extracts were 
concentrated this refers to evaporation under reduced pressure on a rotary evaporator. When anhydrous 
conditions were necessary the glassware and solvents were dried and the additions or transfers were 
made via gas-tight syringes or stainless steel tubing, under a positive pressure of nitrogen. Light 
petroleum refers to a fraction boiling between 60–80 °C. 
3.2. Synthesis of 6,7-Dimethoxy-2-methyl-1-(1-phenylethenyl)-1,2,3,4-tetrahydroisoquinoline (3) 
A solution of 1-phenylethenylmagnesium bromide was prepared by the dropwise addition of 
1-bromostyrene (15.0 g, 81.9 mmol) to magnesium turnings (2.22 g, 91.3 mmol) in dry THF (200 mL) 
under nitrogen over 45 min. The mixture was heated briefly to initiate the reaction at the start of the 
addition with an iodine crystal present. The reaction temperature was then kept below 35 °C.  
The solution was stirred for 30 min. after the addition had ceased. 
The solution of 1-phenylethenylmagnesium bromide in THF was cooled to <−50 °C in an 
acetone/liquid nitrogen bath and then the salt 6,7-dimethoxy-2-methyl-3,4-dihydroisoquinolinium 
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iodide (13.52 g, 40.6 mmol; prepared from 6,7-dimethoxy-3,4-dihydroisoquinoline [23] on reaction 
with excess iodomethane in toluene at room temperature) was added. The mixture was stirred at  
<−50 °C for 90 min and then allowed to warm slowly to room temperature with stirring for 16 h before 
the careful addition of ice to decompose excess Grignard reagent. The mixture was basified by the 
addition of 40% aqueous potassium hydroxide and Et2O (150 mL) was added. The organic layer was 
decanted from the precipitated inorganic salts then centrifuged to remove any residual solids, washed 
with water (150 mL), and then concentrated. The residue was dissolved in Et2O (240 mL) which had 
been used, in three portions, to extract the inorganic solids and then the aqueous wash. The ether 
solution was washed with water (30 mL) then saturated brine (2 × 20 mL), and then dried and passed 
through a silica plug. Concentration of the solution afforded a solid which recrystallised to give the 
title compound 3 (11.11 g, 88%) as a pale yellow powder, mp 80–82 °C (EtOH). IR (KBr disc): 2768, 
1514, 1256, 1217, 1143, 783 cm−1; lH-NMR δ: 7.33–7.28 (m, 2ArH''), 7.22–7.17 (m, 3ArH''), 6.72  
(s, ArH), 6.59 (s, ArH), 5.60 (d, J = 1.6 Hz, H2'), 5.34 (d, J = 1.6 Hz, H2'), 4.09 (s, H1), 3.84  
(s, OCH3), 3.72 (s, OCH3), 3.10-3.02 (m, 2H), 2.66–2.45 (m, 2H), 2.33 (s, NCH3); 13C-NMR δ: 149.9, 
147.9, 147.8, 140.3, 128.9, 128.5, 128.2, 128.0, 127.2, 119.1, 111.6, 110.6, 73.7, 56.3 (2 × OCH3), 
52.0, 44.7, 29.4; m/z: 308 (M-H+, 0.5%; Calcd for C20H22NO2 308.1650, found 308.1647), 206 (100), 
190 (8), 162 (4), 132 (2), 103 (2), 77 (4); Anal. Calcd for C20H23NO2: C, 77.64; H, 7.49; N,  
4.53. found: C, 77.67; H, 7.64; N, 4.42%. 
3.3. Ethyl (E and Z)-9,10-Dimethoxy-3-methyl-6-phenyl-2,3,4,5-tetrahydro-1H-3-benzazonine-4-
carboxylate (E-1 and Z-1) 
The base 3 (2.224 g, 7.19 mmol) was stirred in dry butanone (7 mL) under nitrogen with ethyl 
bromoacetate (1.81 g, 10.8 mmol) for 10 h at 50 °C. Concentration of the solution and trituration of the 
residue with Et2O (4 × 20 mL) afforded a gum which, on concentration from a solution in DCM, gave 
a mixture (trans/cis = 58:42) of the B-ring diastereomers of the 2-ethoxycarbonylmethylisoquino-
linium bromide salts of 3 (1.183 g, 47%) as a tan hygroscopic powder; trans diastereomer (clear 
signals) 1 3 C - N M R  δ: 165.4, 143.4, 139.6, 131.4, 74.2–73.6 (bs), 63.2, 61.2, 56.5 (2 × OCH3), 53.8, 
47.1, 23.8, 14.1; cis diastereomer (clear signals) 13C-NMR δ: 165.2, 142.5, 138.6, 130.7, 74.2–73.6 
(bs), 63.0, 58.2, 56.5, 54.8, 49.8, 23.1, 14.1. 
The trans/cis bromoacetate salt mixture above (307 mg, 0.644 mmol) was then stirred in dry 
acetonitrile (15 mL) under nitrogen at room temperature with DBU (170 mg, 0.84 mmol) for 5 h then 
the solution was concentrated. Purification of the residue by column chromatography on alumina with 
DCM/20% light petroleum afforded a pale yellow oil (206 mg, 81%). 1H-NMR analysis of this oil 
indicated a mixture of four components attributed to Z-1/E-1:6/8 in the ratio of 37:53:8:2. A portion 
(160 mg) of this mixture was purified by preparative reverse phase HPLC with acetonitrile/36% water 
to give: 
(a): After 27.0 min, a mixture (9 mg) of two components (67:33) attributed to 6 and 8. Compound 6 
1H-NMR δ: 7.42–7.25 (m, 5ArH''), 6.72 (s, ArH), 6.63 (s, ArH), 5.33 (s, H2'), 4.91 (s, H2'), 4.50 (d,  
J = 6.5 Hz, H2), 4.08-3.98 (m, 2H), 3.86 (s, OCH3), 3.82 (s, OCH3), 3.66 (d, J = 6.5 Hz, H1),  
3.30–3.15 (m, 2H), 2.75–2.65 (m, 2H), 2.29 (s, NCH3), 1.18–1.12 (m, 3H); 13C-NMR (clear signals) δ: 
172.6, 116.5, 67.0, 60.5, 53.3, 50.4, 46.6, 35.8, 15.1. Compound 8 lH-NMR δ: 7.64 (dd, J = 1.4 Hz, 
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7.6 Hz, 2ArH), 7.42–7.25 (m, 3ArH), 7.06 (s, 1H), 6.96 (s, 1H), 6.89 (s, 1H), 6.80 (dd, J = 11.0,  
17.0 Hz, 1H), 5.57 (dd, J = 1.0, 17.0 Hz, 1H), 5.17 (dd, J = 1.0, 11.0 Hz, 1H), 4.08–3.98 (m, 2H), 3.94 
(s, OCH3), 3.91 (s, OCH3), 3.61 (s, 2H), 3.15 (s, 2H), 2.25 (s, NCH3), 1.20–1.14 (m, 3H); 13C-NMR 
(clear signals) δ: 171.6, 113.8, 60.8, 58.3, 55.2, 42.7, 14.8. 
(b): After 32.8 min, the benzazonine isomer Z-1 (50 mg) which recrystallised as colourless needles 
with mp 101–102 °C (EtOH). lH-NMR (C6D6 at 75 °C) δ: 7.56 (d, J = 7.3 Hz, 2ArH''), 7.01–6.91  
(m, 3ArH''), 6.74 (s, 1H), 6.60 (s, 1H), 6.56 (s, 1H), 4.10–3.82 (bs, CH2 of Et), 3.53 (s, OCH3), 3.45 (s, 
OCH3), 3.41–3.31 (m, H4), 3.01–2.94 (m, 4H), 2.66–2.57 (bs, H), 2.48 (s, NCH3), 2.42–2.36 (bs, H), 
0.97–0.91 (m, 3H); 13C-NMR (C6D6) δ: 173.0, 150.0, 149.7, 141.3, 133.4, 132.6, 131.5, l17.6, 114.7, 
66.0, 60.8, 58.0 (bs), 57.1, 57.0, 41.5, 37.5 (bs), 14.9, NCH3 not observed; lH-NMR (CDCl3 at  
−50 °C): conformer 1 δ: 6.88 (s, 1H), 6.54 (s, 1H), 6.38 (s, 1H), 3.98 (s, OCH3), 3.83 (s, OCH3), 2.36 
(s, CH3), 1.41–1.35 (m, 3H); conformer 2 δ: 6.82 (s, 1H), 6.67 (s, 1H), 6.45 (s, 1H), 3.93 (s, OCH3), 
3.64 (s, OCH3), 2.69 (s, CH3), 0.87–0.81 (m, 3H); m/z: 395 (M+, 27%; Calcd. for C24H29NO4 395.2096, 
found 395.2098), 377 (6), 322 (100), 291 (14), 265 (10); Anal. Calcd. For C24H29NO4: C, 72.88; H, 
7.39; N, 3.54. Found: C, 72.69; H, 7.40; N, 3.36%. 
(c): After 38.8 min, the benzazonine isomer E-1 (54 mg) which recrystallised as colourless prisms with 
mp 124–125 °C (EtOH). lH-NMR (CDCl3) δ: 7.52–7.49 (m, 2ArH''), 7.41–7.31 (m, 3ArH''), 6.78 (s, 
ArH), 6.61 (s, 1ArH and H7), 4.11–4.01 (m, 2H), 3.88 (s, OCH3), 3.83 (s, OCH3), 3.32 (dd,  
J = 3.3, 12.4 Hz, H4), 2.96–2.91 (m, 2H), 2.80–2.69 (m, 3H), 2.56–2.46 (m, 1H), 2.41 (s, NCH3), 
1.24–1.18 (m, 3H); 13C-NMR δ: 174.3, 148.4, 147.4, 143.5, 141.7, 134.7, 130.3, 130.0, 129.1 (2C), 
128.0, 127.4 (2C), l13.9, 112.4, 65.2, 60.7, 56.5 (2 × OCH3), 52.8, 45.1, 38.3, 34.8, 15.0; lH-NMR 
(C6D6) δ: 7.56 (d, J = 8.4 Hz, 2ArH”), 7.30–7.17 (m, 3ArH”), 6.91 (s, H7), 6.65 (s, H8), 6.59 (s, H11), 
3.97–3.87 (m, 2H), 3.56 (dd, J = 4.1, 12.0 Hz, H4), 3.49 (s, OCH3), 3.48 (s, OCH3), 3.35 (dd, J = 3.3, 
15.5 Hz, H4), 3.07–2.88 (m, 4H), 2.78–2.70 (m, 1H), 2.47 (s, NCH3), 0.96–0.90 (m, 3H); 13C-NMR 
(C6D6) δ: 173.8, 149.6, 148.6, 143.5, 142.0, 134.7, 130.5, 113.9, 112.4, 65.5, 60.2, 55.9 (2 × OCH3), 
53.2, 45.2, 38.8, 35.1, 14.7; m/z: 395 (M+, 29%; Calcd for C24H29NO4 395.2096, found 395.2099), 377 
(6), 322 (100), 291 (11), 265 (9); Anal. Calcd for C24H29NO4: C, 72.88; H, 7.39; N, 3.54. Found: C, 
72.99; H, 7.58; N, 3.62%. 
(ii): The bromoacetate salt above (297 mg, 0.623 mmol) was stirred in dry acetonitrile (15 mL) under 
nitrogen (10 mL) with DBU (0.12 g, 0.81 mmol) between −15 °C and −20 °C for 6 h. Workup as for 
(i) above afforded a mixture (200 mg, 81%) of Z-1/E-1:6 in the ratio of 38:54:8. 
(iii): To the bromoacetate salt above (401 mg, 0.842 mmol) in refluxing dry acetonitrile (15 mL) was 
added DBU (170 mg, 1.1 mmol). The solution was refluxed for 1 h. Workup as for (i) above afforded a 
mixture (281 mg, 84%) of four components attributed to Z-1/E-1:6:8 in the ratio of 36:35:11:18. 
Preparative reverse phase HPLC as for (i) afforded, after 27.0 min, a mixture (45 mg) of two 
components (37:63) attributed to 6 and 8. 
3.4. 6,7-Dimethoxy-2-methyl-1-(1-phenylethenyl)-1,2,3,4-tetrahydroisoquinoline N-oxide (5) 
Whenever possible, solutions were cooled in ice throughout this procedure. To 3 (1.486 g,  
4.803 mmol) in DCM (25 mL) at 0 °C was added a solution of m-CPBA (1.021 g, 5.936 mmol) in 
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DCM (25 mL). The solution was stirred at 0 °C for 20 h then 5% aqueous sodium bicarbonate (30 mL) 
was added and the organic solvent was removed in vacuo. The cooled aqueous solution was washed 
with Et2O (3 × 10 mL) then made acidic to litmus with 3 M aqueous hydrochloric acid and washed 
with further Et2O (3 × 15 mL). The solution was basified with saturated aqueous sodium bicarbonate 
then saturated with sodium chloride and extracted with CHCl3 (3 × 25 mL). Drying and then concentration 
of the organic extracts afforded a 4:1 mixture of the N-oxide 5 and 2 (1.525 g). Purification of a portion 
(1.161 g) of this mixture by column chromatography on alumina with DCM/0-10% MeOH gave: 
(a): A 78:22 mixture of 2 and 7 (156 mg, 14%).  
(b): The trans-B-ring diastereomer of the tetrahydroisoquinoline N-oxide 5 (547 mg, 47%) as a cream 
hygroscopic solid. lH-NMR 5: 7.30 (s, 3ArH''), 7.07 (bs, o-ArH''), 6.71 (s, ArH), 6.62 (s, ArH), 5.61 (s, 
H1), 5.30 (s, 2H2'), 3.91 (s, OCH3), 3.83 (s, OCH3), 3.73–3.60 (m, 2H), 3.18–3.11 (m, 1H), 3.12 (s, 
NCH3), 2.65–2.58 (m, 1H); 13C-NMR δ: 149.3, 148.9, 147.8, 140.5, 129.4 (2C), 129.0 (2C), 128.0, 
126.1, 124.8, 124.3, 111.6, 82.5, 59.8, 58.7, 56.7, 56.6, 24.9. 
3.5. (Z)-9,10-Dimethoxy-3-methyl-6-phenyl-1,2,3,5-tetrahydro-4,3-benzoxazonine (2) and  
7,8-Dimethoxy-3-methyl-1-(1-phenylethenyl)-1,3,4,5-tetrahydro-2,3-benzoxazepine (7) 
To the tetrahydroisoquinoline 3 (2.056 g, 6.626 mmol) in DCM (40 mL) at 0 °C was added a 
solution of m-CPBA (1.40 g, 8.14 mmol) in DCM (60 mL). The solution was stirred at 0 °C for 40 h 
then 5% aqueous sodium bicarbonate (40 mL) was added and the organic solvent was removed  
in vacuo. The aqueous solution was washed with Et2O (3 × 25 mL) then made acidic to litmus with  
3 M aqueous hydrochloric acid and washed with further Et2O (3 × 15 mL). The solution was basified 
with saturated aqueous sodium bicarbonate then saturated with sodium chloride and extracted with 
CHCl3 (3 × 25 mL). Drying and then concentration of the organic extracts, then column 
chromatography of the residue on alumina with DCM/0-10% MeOH, gave a 44:56 mixture of 2 and 7 
(0.522 g, 24%) and the trans diastereomer of the N-oxide 5 (1.142 g, 53%). Preparative reverse phase 
HPLC of this mixture with acetonitrile/37% H2O gave: 
(a): At 14.3 min, the 2,3-benzoxazepine 7 as colourless prisms with mp 96–97 °C (MeOH). lH-NMR δ: 
7.48–7.45 (m, o-ArH''), 7.33–7.25 (m, 3ArH''), 6.65 (s, ArH), 6.50 (s, ArH), 5.98 (s, H2'), 5.53 (s, H2'), 
5.15 (s, H1), 3.85 (s, OCH3), 3.69 (s, OCH3), 3.45–3.37 (m, 1H), 3.12–3.04 (m, 1H), 2.91–2.86 (m, 
1H), 2.72–2.67 (m, 1H), 2.66 (s, NCH3); 13C-NMR δ: 148.1, 147.9, 147.6, 140.6, 132.8, 130.4, 128.7 
(2C), 128.0, 127.3 (2C), 117.3, 114.2, 111.7, 87.2, 60.6, 56.5, 56.3, 47.2, 33.7; m/z: 325 (M+, 12%; 
Calcd for C20H23NO3 325.1677, found: 325.1670, 308(3), 266(100), 251(16), 237(10), 206(47); Anal. 
Calcd for C20H23NO3: C, 73.87; H, 7.13; N, 4.31. Found: C, 73.98; H, 7.29; N, 4.48%. 
(b): At 17.1 min, the 4,3-benzoxazonine 2 as colourlesss prisms with mp 111–112 °C (MeOH).  
lH-NMR δ: 7.55–7.52 (m, o-ArH'), 7.40–7.24 (3ArH'), 7.00 (s, H7), 6.75 (s, ArH), 6.63 (s, ArH), 4.51 
(bs, H5), 3.89 (s, OCH3), 3.85 (s, OCH3), 2.94 (bs, 2H), 2.65 (s, NCH3), 2H of CH2CH2 not detected; 
13C-NMR δ: 148.8, 147.5, 142.4, 142.1, 133.6, 131.3, 130.8, 129.1 (2C), 127.9, 126.8 (2C), 111.8, 
111.1, 74.6, 63.0, 56.5, 56.4, 47.9, 32.9; m/z: 325 (M+, 13%; Calcd for C20H23NO3 325.1677, found: 
325.1670, 266 (93), 251 (18), 235 (7), 206 (100), 178 (12), 165 (17); Anal. Calcd for C20H23NO3: C, 
73.87; H, 7.13; N, 4.31. Found: C, 73.84; H, 7.10; N, 4.44%. NMR analyses at −30 °C displayed two 
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conformers in a 78:22 ratio. Assignable signals were: lH-NMR δ: 7.11 and 6.92 (s, H7), 6.83 and 6.70 
(s, ArH), 6.67 and 6.63 (s, ArH), 4.87 (d, J = 12.7 Hz, H5a), 4.47 (s, 2H5b), 4.32 (d, J = 12.7 Hz, 
H5a), 2.73 and 2.63 (s, NCH3); 13C-NMR δ: 132.4 and 131.7 (C7), 75.8 and 71.7 (C5), 63.0 and 62.9 
(C2), 48.8 and 46.5 (NCH3), 31.7 and 34.3 (C1). 
3.6. X-ray Structure Determinations 
Full spheres of CCD area detector data were measured at “low”-temperature, (ω-scans, 
monochromatic Mo Kα radiation, λ = 0.71073 Å) yielding N(total) reflections, these being merged after 
“empirical”/multiscan absorption correction to N unique (Rint cited), No with I > 2σ(I) being considered 
“observed”. Full matrix least squares refinements on F2 were undertaken, anisotropic displacement 
parameter forms being refined for C,N,O, hydrogen atom treatment following a riding model, 
reflection weights being [σ2(F2) + (aP)2 + bP]−1 [P = (Fo2 + 2Fc2)/3]. Neutral atom complex scattering 
factors were employed, within the context of the SHELXL97 program [29]. Pertinent results are given 
in Table 3 and in Tables 1–2 and Figures, non-hydrogen atom displacement ellipsoids, where shown, 
being at the 50% probability amplitude levels, hydrogen atoms, where shown, having arbitrary radii of 
0.1 Å. Full .cif depositions, excluding structure factor amplitudes, are lodged with the Cambridge 
Crystallographic Data Centre, CCDC 972658 (2), 972659 (E-1). These data can be obtained free of 
charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC, 12 Union Road, 
Cambridge CB2 1EZ, UK; Fax: +44 1223 336033; E-mail: deposit@ccdc.cam.ac.uk). 
4. Conclusions 
Derivatization on nitrogen in the common precursor tetrahydroisoquinoline base 3 and subsequent 
Stevens or Meisenheimer rearrangement under mild conditions allows access to the nine-membered 
3-benzazonine 1 (E and Z isomers, with the former predominant) as well as the analogous  
4,3-benzoxazonine system 2 (Z only) with the same phenyl group disposition about the endocyclic 
double bond as for the E-benzazonine. The concerted [2,3] rearrangements involved are favoured when 
the reactive N-ylide or N-oxide functionality is syn to the 1-styrenyl substituent in the  
tetrahydro-isoquinoline precursor, while the competing [1,2] rearrangements to give the isomeric  
seven-membered ring compounds most probably proceed via a diradical intermediate. The nine-membered 
ring systems with the same endocyclic double bond geometry show some differences in ring 
conformations in the solid state from single crystal X-ray studies. Two conformations of E-1 and 2 
were detected by NMR studies in solution at low temperature. Application of catalytic enantioselective 
Meisenheimer [2,3] rearrangement methodology [30,31] to appropriately substituted 1-vinylic 
tetrahydroisoquinoline N-oxides is likely to be of further synthetic interest in the medium ring area. 
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